Lawyer finder

Dr. Luke Kempton

Partner
Luke Kempton

A partner in the Intellectual Property team, specialising in the life sciences sector. I have a PhD in biochemistry and work closely with other members of our experienced Life Sciences team.

Tel: +44 (0)121 629 1834
Email: luke_kempton@wragge.com

Services: Intellectual Property
Business sectors: Life Sciences

Best brains in ...

Patent litigation, licensing, collaborations and manufacturing agreements in the life sciences industry, as well as aspects of pharmaceutical regulatory law.

Highlight of your career so far?

The recent patent case which we won in the Patents Court for Siemens Magnet Technology against the University of Queensland. It involved particularly complex technology.

Most challenging job you've ever done?

Co-ordinating patent litigation in the UK and three other European states for a US East Coast life sciences company relating to its key product. Our expert witness was from the west coast of the US and the client's exclusive licensee, who was involved in all key decisions, was Scandinavian. The matter was eventually settled on advantageous terms for our client.

What about outside the UK?

Most of my work has an international element, but a more extreme example was negotiating an agreement for a Dutch company which was taking a licence from an Italian company and the agreement was subject to Swiss law.

An example of your great client service?

A client in the veterinary products business called from a trade fair to say that a competitor was launching an infringing product at that fair. Within an hour and a half I had analysed the infringing product, drafted a cease and desist letter and travelled to the fair to serve the letter on the infringers who pulled their product immediately.

Best example of a creative legal solution?

I was involved in the first case where the Patents Court sat outside London. We asked it to sit in Birmingham as the lawyers' clients and witnesses were all from that city. We won the case but the court has not repeated the experiment!

When have you ever given a client a real competitive edge?

One of my clients is involved in enforcing patents as an investment. I put him in contact with an inventor who had a patent but could not afford to enforce it. As a result of the subsequent enforcement program we have made several million pounds for the client and the inventor.

What's been written or said about you that you're most proud of?

'I have over 12 years experience in IP licensing and technology transfer – I'd rate Luke as one of the best legal advisors I've come across. I have recommended Wragge & Co to other organisations largely on the basis of Luke's service [to the client]. Luke would be one of only a handful of legal advisors I'd choose from to do business with.'

'Luke did an absolutely superb job for our company and our corporate partner. ... We would without any hesitation re-engage or recommend to a third party Luke Kempton & Wragge & Co for any future work in European litigation matters.'

Alerts

07.07.10

The scope of DNA patents - ECJ's decision in Monsanto v Cefetra

The Court of Justice of the European Union (CJEU) handed down its decision on the scope of protection to be afforded to DNA sequence patents. 

16.04.09

Questions on Supplementary Protection Certificates referred to the European Court of Justice

The English High Court has sought guidance from the European Court of Justice (ECJ) relating to the validity of a Supplementary Protection Certificate.

12.11.08

Be careful what you ask for: Servier payout over £17 million to Apotex under a cross-undertaking in damages

On 9 October 2008, Servier was ordered to pay generics company Apotex £17.5 million under a cross-undertaking in damages given by Servier, in exchange for the grant of an injunction.

07.05.08

NICE result for Eisai

The Court of Appeal has judicially reviewed guidance issued by the National Institute for Clinical Excellence (NICE) concerning the prescription of certain medicines for the treatment of Alzheimers and held it to be procedurally unfair.

 

Press releases

01.04.09

Wragge & Co named European High-Tech Law Firm of the Year

Wragge & Co LLP Intellectual Property (IP) team has been named European High-Tech Law Firm of the Year by Managing Intellectual Property.

18.03.09

Wragge & Co advises the Department of Health on nationwide data collection programme

Wragge & Co LLP has advised the Department of Health on a three-year contract to implement a market-leading nationwide patient outcomes data collection programme.

17.03.09

Wragge & Co advises Eisai on cross-border €95 million epilepsy deal

Wragge & Co LLP Life Sciences team has advised Eisai Europe Limited on a cross-border €95 million licence and co-promotion agreement with Bial-Portela & CA, S.A for the treatment for epilepsy.

17.06.08

Wragge & Co Life Sciences team advises Astex on $500 million drug discovery alliance

Wragge & Co LLP Life Sciences team has advised Astex Therapeutics Limited on a landmark $500 million drug discovery alliance with Janssen Pharmaceutica N.V.

28.04.08

Regulatory specialist joins Wragge & Co's Life Sciences team

Wragge & Co LLP has boosted its Life Sciences practice with a new regulatory specialist. Liz Fuller joins as director, life sciences regulatory (US qualified), bringing expertise in pharmaceutical and biotech regulatory affairs.

08.04.08

Wragge & Co expands IP practice with two new partners

Wragge & Co LLP has boosted its intellectual property practice with the appointment of Alexandra Brodie and Dr Luke Kempton as partners.

02.04.08

Wragge & Co's Life Sciences practice grows

Wragge & Co LLP has boosted its Life Sciences practice with the appointment of Dr Luke Kempton as a partner. With significant expertise in life sciences litigation, Luke will be a major force in driving forward the life sciences practice.

 

Published articles

There are currently no published articles for Luke Kempton.

 

Search for lawyer